Nuubo has announced it has received FDA 510(k) clearance to market its Nuubo System, a disruptive wireless, textile-based ambulatory electrocardiogram (aECG) technology that enables mid and long-term monitoring for cardiac arrhythmia diagnosis. The Nuubo System is designed to obtain the highest ECG signal quality while achieving best-in-class patient comfort for monitoring up to 30 days.